SEARCH

SEARCH BY CITATION

References

  • Arunlakshana, A.O. & Schild, H.O. (1959). Some quantitative uses of drug antagonist. Br. J. Pharmacol. Chemother., 14, 153161.
  • Banks, B.E.C., Brown, C, Burgess, G.M., Burnstock, G., Claret, M., Cocks, T.M. & Jenkinson, D.H. (1979). Apamin blocks certain neurotransmitter-induced increases in potassium permeability. Nature, 282, 415417.
  • Bennett, A., Eley, K.G. & Stockley, H.L. (1975). The effects of prostaglandins on guinea-pig isolated intestine and their possible contribution to muscle activity and tone. Br. J. Pharmacol., 54, 197204.
  • Brookes, S.J.H. (1993). Neuronal nitric oxide in the gut. J. Gastroenterol. Hepatol., 8, 590603.
  • Compton, D.R., Gold, L.H., Ward, S.J., Balster, R.L. & Martin, B.R. (1992). Aminoalkylindole analogs: cannabimi-metic activity of a class of compounds structurally distinct from Δ9-tetrahydrocannabinol. J. Pharmacol. Exp. Ther., 263, 11181126.
  • Costa, M., Furness, J.B. & Humphreys, C.M.S. (1986). Apamin distinguishes two types of relaxation mediated by enteric nerves in the guinea-pig gastrointestinal tract. Naunyn-Schmiedeberg's Arch. Pharmacol., 332, 7988.
  • Coutts, A.A. & Pertwee, R.G. (1997). Inhibition by cannabinoid receptor agonists of acetylcholine release from the guinea-pig myenteric plexus. Br. J. Pharmacol., 121, 15571566.
  • Crist, J.R., He, X.D. & Goyal, R.K. (1992). Both Atp and the peptide Vip are inhibitory neurotransmitters in guinea-pig ileum circular muscle. J. Physiol., 447, 119131.
  • Devane, W.A., Dysarz, F.A., Johnson, M.R., Melvin, L.S. & Howlett, A.C. (1988). Determination and characterization of a cannabinoid receptor in rat brain. Mol. Pharmacol., 34, 605613.
  • Devane, W.A., Hanus, L., Breuer, A., Pertwee, R.G., Stevenson, L.A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A. & Mechoulam, R. (1992). Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science, 258, 19461949.
  • Gifford, A.N. & Ashby, C.R. (1996). Electrically evoked acteylcho-line release from hippocampal slices is inhibited by the cannabinoid receptor agonist, Win 55212-2, and is potentiated by the cannabinoid antagonist, Sr 141716A. J. Pharmacol. Exp. Ther., 277, 14311436.
  • Griffin, G., Fernando, S.R., Ross, R.A., Mckay, N.G., Ash-Ford, M.L.J., Shire, D., Huffman, J.W., Yu, S., Lainton, J.A.H. & Pertwee, R.G. (1997). Evidence for the presence of Cb2-like cannabinoid recepotrs on peripheral nerve terminals. Eur. J. Pharmacol., 339, 5361.
  • Howlett, A.C. (1995). Pharmacology of cannabinoid receptors. Annu. Rev. Pharmacol. Toxicol., 35, 607634.
  • Izzo, A.A., Mascolo, N., Costa, M. & Capasso, F. (1997). Effect of papaverine on synaptic transmission in the guinea-pig ileum. Br. J. Pharmacol., 121, 768772.
  • Kosterlitz, H.W. & Lees, G.M. (1964). Pharmacological analysis of intrinsic intestinal reflexes. Pharm. Rev., 16, 301339.
  • Kromer, W. (1988). Endogenous and exogenous opioids in the control of gastrointestinal motility and secretion. Pharmacol. Rev., 40, 121162.
  • Layman, J.M. & Milton, A.S. (1971). Some action of Δ1-tetrahydrocannabinol and cannabinol at cholinergic junctions. Br. J. Pharmacol. Proc. Suppl., 40, 553P.
  • Lopez-Redondo, F., Lees, G.M. & Pertwee, R.G. (1997). Effects of cannabinoid receptor ligands on electrophysiological properties of myenteric neurones of the guinea-pig ileum. Br. J. Pharmacol., 122, 330384.
  • Maggi, C.A. & Giuliani, S. (1996). Evidence that tachykinin Nk2 receptors modulate resting tone in the rat isolated small intestine. Br. J. Pharmacol., 118, 12621268.
  • Maggi, C.A, Patacchini, R., Meini, S. & Giuliani, S. (1993). Nitric oxide is the mediator of tachykinin Nk3 receptor-induced relaxation in the circular muscle of the guinea-pig ileum. Eur. J. Pharmacol., 240, 4550.
  • Mechoulam, R., Ben-Shabat, S., Hanus, L., Ligumsky, M., Kaminski, N.E., Schatz, A.R., Gopher, A., Almog, S., Martin, B.R., Compton, D.R., Pertwee, R.G., Griffin, G., Bayewitch, M., Barg, J. & Vogel, Z. (1995). Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to a cannabinoid receptor. Biochem. Pharmacol., 50, 8390.
  • Munro, S., Thomas, K.L. & Abu-Shaar, M. (1993). Molecular characterization of a peripheral receptor for cannabinoids. Nature, 365, 6165.
  • Pertwee, R.G. (1997). Pharmacology of cannabinoid Cb1 and Cb2 receptors. Pharmacol. Ther., 74, 129180.
  • Pertwee, R.G. & Fernando, S.R. (1996). Evidence for the presence of cannabinoid Cb1 receptors in mouse urinary bladder. Br. J. Pharmacol., 118, 20532058.
  • Pertwee, R.G., Fernando, S.R., Griffin, G., Abadji, V. & Makriyannis, A. (1995). Effect of phenylmethylsulphonyl fluoride on the potency of anandamide as an inhibitor of electrically-evoked contractions in two isolated tissue preparations. Eur. J. Pharmacol., 272, 7378.
  • Pertwee, R.G., Fernando, S.R., Griffin, G., Ryan, W.L., Razdan, R.K., Compton, D.R. & Martin, B.R. (1996a). Agonist-antagonist characterization of 6′-cyanohex-2′-yne-Δ8-tetrahydrocannabinol in two isolated tissue preparations. Eur. J. Pharmacol., 315, 195201.
  • Pertwee, R.G., Fernando, S.R., Nash, J.E. & Coutts, A.A. (1996b). Further evidence for the presence of cannabinoid Cb1 receptors in guinea-pig small intestine. Br. J. Pharmacol., 118, 21992205.
  • Pertwee, R.G., Stevenson, L.A., Elrick, D.B., Mechoulam, R. & Corbett, A.D. (1992). Inhibitory effects of certain enantiomeric cannabinoids in the mouse vas deferens and the myenteric plexus preparation of guinea-pig small intestine. Br. J. Pharmacol., 105, 980984.
  • Rand, M.J. & Li, C.G. (1993). Modulation of acetylcholine-induced contractions of the rat anococcygeus muscle by activation of nitrergic nerves. Br. J. Pharmacol., 110, 14791482.
  • Rinaldi-Carmona, M., Barth, F., Heaulme, M., Alonso, R., Shire, D., Congy, C, Soubrie', P., Breliere, J.-C. & Le Fur, G. (1995). Biochemical and pharmacological characterization of Sr141716A, the first potent and selective brain cannabinoid receptor antagonist. Life Sci., 56, 19411947.
  • Rinaldi-Carmona, M., Barth, F., Heaulme, M., Shire, D., Calandra, B., Congy, C., Martinez, S., Maruani, J., Neliat, G., Caput, D., Ferrara, P., Soubrie, P., Breliere, J.-C. & Le Fur, G. (1994). Sr141716A, a potent and selective antagonist of the brain cannabinoid receptor. Febs Lett., 350, 240244.
  • Schlicker, E., Timm, J. & Gothert, M. (1996). Cannabinoid receptor-mediated inhibition of dopamine release in the retina. Naunyn-Schmiedelberg's Arch. Pharmacol., 354, 791795.
  • Terranova, J.-P., Michaud, J.-P., Le Fur, G. & Soubrie', P. (1995). Inhibition of long-term potentiation in rat hippocampal slices by anandamide and Win55212-2: reversal by Sr141716A, a selective antagonist of Cb1 cannabinoid receptors. Naunyn-Schmiedeberg's Arch. Pharmacol., 352, 576579.
  • Welch, S.P., Dunlow, L.D., Patric, G.S. & Razdan, R.K. (1995). Characterization of anandamide- and fluoroanandamide-in-duced antinociception and cross-tolerance to delta 9-Thc after intrathecal administration to mice: blockade of delta 9-Thc-induced antinociception. J. Pharmacol. Exp. Ther., 273, 12351244.
  • Wood, J.D. (1987). Physiology of the enteric nervous system. In Physiology of the Gastrointestinal Tract. ed Johnson, L.R. pp. 67110. New York: Raven Press.